Journal of Cachexia, Sarcopenia and Muscle最新文献

筛选
英文 中文
A Murinized Bimagrumab Analogue Increases Skeletal Muscle Mass and Improves Cardiometabolic Remodelling in Experimental Hypertrophic Cardiomyopathy 鼠化倍马单抗类似物增加实验性肥厚性心肌病的骨骼肌质量并改善心脏代谢重塑
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-11-11 DOI: 10.1002/jcsm.70420
Tomas Baka, Sophia M. Mirrione, Fuzhong Qin, Adam C. Gower, Huamei He, Connor Haney, Kuan Ming Su, Simon T. Dillon, Towia A. Libermann, Kylie Heitman, Andrew P. Ryan, Joseph T. Brozinick, Francesca Seta, David R. Pimentel, Flora Sam, Ivan Luptak
{"title":"A Murinized Bimagrumab Analogue Increases Skeletal Muscle Mass and Improves Cardiometabolic Remodelling in Experimental Hypertrophic Cardiomyopathy","authors":"Tomas Baka, Sophia M. Mirrione, Fuzhong Qin, Adam C. Gower, Huamei He, Connor Haney, Kuan Ming Su, Simon T. Dillon, Towia A. Libermann, Kylie Heitman, Andrew P. Ryan, Joseph T. Brozinick, Francesca Seta, David R. Pimentel, Flora Sam, Ivan Luptak","doi":"10.1002/jcsm.70420","DOIUrl":"https://doi.org/10.1002/jcsm.70420","url":null,"abstract":"Background Hypertrophic cardiomyopathy (HCM) involves left ventricular hypertrophy and metabolic dysfunction. Given the role of skeletal muscle in systemic metabolism, we investigated whether activin type II receptor inhibition with CDD866, a murinized bimagrumab analogue that induces skeletal muscle hypertrophy, improves physical performance and cardiometabolic remodelling in established HCM. Methods Twenty‐four‐week‐old male mice harbouring the cardiac myosin R403Q mutation received CDD866 or isotype antibody (20 mg/kg subcutaneously every 3 days) for 4 weeks; wild‐type (WT) littermates received isotype antibody. Assessments included body composition, muscle imaging and histology, grip strength, treadmill exercise, glucose tolerance, echocardiography, cardiac histopathology, myocardial substrate oxidation by <jats:sup>13</jats:sup> C nuclear magnetic resonance in isolated beating hearts and cardiac transcriptomics and proteomics. Values are mean ± SEM. Results Compared with R403Q placebo, CDD866 increased lean mass (22.5 ± 0.6 vs. 18.7 ± 0.5 g; <jats:italic>p</jats:italic> < 0.001), grip strength (135.3 ± 3.4 vs. 99.9 ± 4.3 cN; <jats:italic>p</jats:italic> < 0.0001) and treadmill distance (99.8 ± 1.7 vs. 77.2 ± 3.2 m; <jats:italic>p</jats:italic> < 0.0001). Hindlimb muscle volume increased by 24 ± 8% ( <jats:italic>p</jats:italic> < 0.05), and individual muscle weights increased by 44%–87% (all <jats:italic>p</jats:italic> < 0.0001). CDD866 reduced total left ventricular wall thickness (1.80 ± 0.03 vs. 1.98 ± 0.03 mm; <jats:italic>p</jats:italic> < 0.001) and improved E/A ratio (1.31 ± 0.04 vs. 0.99 ± 0.04; <jats:italic>p</jats:italic> < 0.001) and early diastolic mitral annular velocity (18.6 ± 0.7 vs. 14.0 ± 0.7 mm/s; <jats:italic>p</jats:italic> < 0.01). Cardiomyocyte cross‐sectional area and myocardial fibrosis decreased by 32 ± 6% ( <jats:italic>p</jats:italic> < 0.0001) and 69 ± 31% ( <jats:italic>p</jats:italic> < 0.01), respectively. Glucose tolerance was impaired in R403Q mice versus WT ( <jats:italic>p</jats:italic> < 0.01), with a nonsignificant reduction in AUC following CDD866 ( <jats:italic>p</jats:italic> = 0.223). CDD866 increased the fractional contribution of fatty acids to myocardial oxidative metabolism (0.66 ± 0.02 vs. 0.38 ± 0.05; <jats:italic>p</jats:italic> < 0.01) and reduced <jats:sup>13</jats:sup> C‐lactate output (15.3 ± 2.5 vs. 40.2 ± 3.8 nmol/min; <jats:italic>p</jats:italic> < 0.001). Consistent with these measurements, cardiac RNA‐seq GSEA showed HCM‐associated suppression and CDD866‐associated enrichment of fatty acid oxidation, pyruvate metabolism, the tricarboxylic acid cycle, oxidative phosphorylation, ATP synthesis and branched‐chain amino acid catabolism (all FDR <jats:italic>q</jats:italic> < 0.05). Integrated transcriptomic and proteomic upstream regulator predictions provided an exploratory regulatory context for these metabolic findings. Conclusions CDD866 incre","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"10 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ZIF‐8‐Based Nanodelivery of Tectorigenin for Alleviating Skeletal Muscle Atrophy via Inhibition of Oxidative Stress and Inflammation 基于ZIF‐8的纳米递送鸢尾黄素通过抑制氧化应激和炎症缓解骨骼肌萎缩
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-11-10 DOI: 10.1002/jcsm.70418
Xia Li, Yutong Wei, Lei Qi, Xiu Dai, Zhanzhan Li, Chuli Zhu, Xucheng Zhu, Yuntian Shen, Bingqian Chen, Xiaosong Gu, Hualin Sun, Xinlei Yao
{"title":"ZIF‐8‐Based Nanodelivery of Tectorigenin for Alleviating Skeletal Muscle Atrophy via Inhibition of Oxidative Stress and Inflammation","authors":"Xia Li, Yutong Wei, Lei Qi, Xiu Dai, Zhanzhan Li, Chuli Zhu, Xucheng Zhu, Yuntian Shen, Bingqian Chen, Xiaosong Gu, Hualin Sun, Xinlei Yao","doi":"10.1002/jcsm.70418","DOIUrl":"https://doi.org/10.1002/jcsm.70418","url":null,"abstract":"Background Skeletal muscle atrophy is a pathological condition characterized by a progressive loss of muscle mass and function. Its core mechanisms involve an imbalance between protein synthesis and degradation, caused by oxidative stress and inflammation. Tectorigenin (TG) shows therapeutic potential but suffers from poor solubility and bioavailability. This study developed a zeolitic imidazolate framework‐8 (ZIF‐8) nanocarrier for TG (ZIF‐8@TG) to enhance delivery efficacy against neurogenic muscle atrophy. Methods ZIF‐8@TG nanoparticles were synthesized and characterized for size, drug loading, release profile and cytotoxicity. Their therapeutic effects were investigated in vitro using a nutrient deprivation‐induced C2C12 myotube atrophy model and in vivo using a sciatic nerve crush injury–induced mouse model of muscle atrophy. Immunofluorescence staining and western blotting were performed to assess the effects of ZIF‐8@TG on atrophic myotubes. Behavioural tests, immunofluorescence staining and western blotting were used to evaluate its impact on muscle atrophy in vivo. The underlying mechanisms were further explored through western blotting, electron microscopy, immunofluorescence staining and H&amp;E staining. Results ZIF‐8@TG nanoparticles (approx. 50 nm) exhibited pH‐responsive release and efficient cellular uptake. In vitro, nutrient deprivation reduced myotube diameter by 53% ( <jats:italic>p</jats:italic> &lt; 0.01), whereas ZIF‐8@TG treatment restored it to 92% of control levels, showing significantly better efficacy than free TG. In vivo, sciatic nerve injury decreased tibialis anterior muscle mass by 35% ( <jats:italic>p</jats:italic> &lt; 0.001) and mean myofiber cross‐sectional area (CSA) by 41% ( <jats:italic>p</jats:italic> &lt; 0.001). ZIF‐8@TG treatment significantly increased muscle mass to 74% and CSA to 93% of control values, whereas free TG resulted in non‐significant improvements. Additionally, ZIF‐8@TG improved motor function in mice following sciatic nerve crush. Mechanistically, the alleviation of skeletal muscle atrophy by ZIF‐8@TG may be associated with regulation of excessive activation of the ubiquitin‐proteasome system and autophagy‐associated changes, along with enhanced protein synthesis–related Akt/mTOR signalling pathway during sciatic nerve crush–induced muscle atrophy, as well as an association with reduced oxidative stress and inflammation. Conclusions ZIF‐8@TG effectively delivers TG, alleviating muscle atrophy in vitro and in vivo. ZIF‐8@TG treatment is associated with reduced oxidative stress and inflammation, preserved protein homeostasis and improved functional recovery, offering a promising nanotechnology‐based therapy strategy for neurogenic skeletal muscle atrophy.","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"17 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149374287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deuterium‐Oxide Labelling Proteomics Illustrates the Importance of Sample Timing and the Limitations of Serial Biopsies 氧化氘标记蛋白质组学说明了采样时间的重要性和系列活检的局限性
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-11-10 DOI: 10.1002/jcsm.70426
Colleen L. O'Reilly, Michael E. Taylor, Kamil A. Kobak, Ying Ann Chiao, Rovshan G. Sadygov, Michael T. Kinter, Benjamin F. Miller
{"title":"Deuterium‐Oxide Labelling Proteomics Illustrates the Importance of Sample Timing and the Limitations of Serial Biopsies","authors":"Colleen L. O'Reilly, Michael E. Taylor, Kamil A. Kobak, Ying Ann Chiao, Rovshan G. Sadygov, Michael T. Kinter, Benjamin F. Miller","doi":"10.1002/jcsm.70426","DOIUrl":"https://doi.org/10.1002/jcsm.70426","url":null,"abstract":"Background Measuring in vivo protein synthesis is important for testing how interventions, disease and ageing remodel the proteome. A limitation of approaches using short‐term infusions of labelled amino acids was that long‐term changes had to be extrapolated from short‐term measurements. Deuterium oxide (D <jats:sub>2</jats:sub> O) is now widely used because it can measure protein synthesis over periods of days to weeks. We previously showed that the duration of labelling impacts measured protein synthesis, but many still employ repeated tissue sampling during D <jats:sub>2</jats:sub> O provision. We hypothesized that the timing of tissue sampling alters which proteins contribute to the overall protein fractional synthesis rate (FSR), thereby invalidating comparisons between serial samples collected during continuous labelling. Methods To test this hypothesis, we used a five‐timepoint (0d, 4d, 15d, 30d and 45d) D <jats:sub>2</jats:sub> O labelling time course followed by liquid chromatography–tandem mass spectrometry proteomics to calculate individual protein synthesis rates and plateau values in mouse gastrocnemius muscle. Individual proteins were stratified into slow and fast groups, such that each group was responsible for the slowest or fastest 20% of total synthesis over the first 4 days of labelling, respectively. Results In a 4‐day period representing a baseline period, the synthesis rate of summed proteins was 2.09%/day. When the period was extended to 15, 30 or 45 days, the synthesis rates of summed proteins declined to 1.64%, 1.31% and 1.10%/day, respectively. The contribution of slow and fast proteins to these rates changed as a function of time. The fast and slow proteins accounted for 4.3% and 34.0% of measured proteome abundance, respectively. From Day 0 to Day 4, fast and slow proteins contributed 19.8% and 20.2% of the calculated FSR, respectively. By Day 45, these contributions shifted to 6.5% and 28.8%. Further, we demonstrated that the assumption that the fraction new of proteins linearly increases to 100% new is not true for the majority of proteins. Instead, most proteins plateaued at some point less than 100%, which stops their individual contribution to a summed protein synthesis rate. Conclusions In continuous long‐term labelling studies, biopsy timing changes the measured bulk FSR because the relative contributions of individual proteins to that measurement over time. Fast proteins that plateau early decrease their contribution as labelling time increases. These findings indicate that studies with different labelling periods, or multiple biopsies over time during continuous labelling of days to weeks cannot be compared to biopsies taken at other times in the labelling period.","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"12 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149374286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating Tsukushi Predicts Incident Sarcopenia and Functional Decline in Older Adults: A Prospective Cohort Study 循环Tsukushi预测老年人肌肉减少症和功能下降:一项前瞻性队列研究
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-11-09 DOI: 10.1002/jcsm.70423
Ming‐Qing He, Xue‐Ning Dai, Mian Zhang, Yue Yu, Liang Zhou, Jing Wu, Wen‐Ya Zhao, Die‐Jing Niu, Can Zhao, Jin‐Shui Xu, Zheng‐Kai Shen, Xiang Lu, Bin Xue, Wei Gao
{"title":"Circulating Tsukushi Predicts Incident Sarcopenia and Functional Decline in Older Adults: A Prospective Cohort Study","authors":"Ming‐Qing He, Xue‐Ning Dai, Mian Zhang, Yue Yu, Liang Zhou, Jing Wu, Wen‐Ya Zhao, Die‐Jing Niu, Can Zhao, Jin‐Shui Xu, Zheng‐Kai Shen, Xiang Lu, Bin Xue, Wei Gao","doi":"10.1002/jcsm.70423","DOIUrl":"https://doi.org/10.1002/jcsm.70423","url":null,"abstract":"Background Sarcopenia is a major age‐related condition associated with functional decline, disability and mortality in older adults, yet reliable circulating biomarkers for early risk stratification remain limited. Tsukushi (TSK), a secreted hepatokine involved in systemic metabolic regulation, has recently been implicated in skeletal muscle homeostasis. However, prospective clinical evidence linking circulating TSK to sarcopenia development is lacking. We therefore investigated the association between serum TSK levels and incident sarcopenia in a community‐based cohort of older adults. Methods A total of 1370 community‐dwelling individuals aged ≥ 65 years were followed for 4 years. Baseline serum TSK levels were measured using enzyme‐linked immunosorbent assay. Multivariable Cox proportional hazards models were used to assess the association between TSK and incident sarcopenia after adjustment for confounding factors. Restricted cubic spline analyses were applied to explore dose–response relationships, and predictive performance was evaluated using time‐dependent receiver operating characteristic (ROC) curves. Results Lower baseline TSK levels were associated with a higher cumulative incidence of sarcopenia. In multivariable analyses, higher TSK levels were associated with a lower risk of incident sarcopenia (hazard ratio per SD increase = 0.64, 95% CI = 0.53–0.76, <jats:italic>p</jats:italic> &lt; 0.001). Dose–response analyses demonstrated a non‐linear association with overall sarcopenia risk, whereas associations with low muscle strength and low physical performance were more nearly linear. The association appeared more evident in women than in men. TSK alone showed moderate discrimination for incident sarcopenia (AUC = 0.700), while a combined clinical model improved discrimination (AUC = 0.808 at 4 years). Conclusions Lower circulating TSK levels are associated with a higher risk of incident sarcopenia in older adults, particularly subsequent muscle‐related functional decline. TSK may be a candidate biomarker for early sarcopenia risk stratification and may reflect systemic metabolic processes relevant to muscle health.","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"7 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149374288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating MicroRNAs Reflect Systemic Inflammation and Metabolic Dysfunction in Oesophageal Squamous Cell Carcinoma–Associated Cachexia 循环microrna反映食道鳞状细胞癌相关恶病质的全身炎症和代谢功能障碍
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-10-22 DOI: 10.1002/jcsm.70409
Yan Li,Rui Chen,Xinyi Lv,Shujuan Wei,Yiming Xu,Shengguang Ding
{"title":"Circulating MicroRNAs Reflect Systemic Inflammation and Metabolic Dysfunction in Oesophageal Squamous Cell Carcinoma–Associated Cachexia","authors":"Yan Li,Rui Chen,Xinyi Lv,Shujuan Wei,Yiming Xu,Shengguang Ding","doi":"10.1002/jcsm.70409","DOIUrl":"https://doi.org/10.1002/jcsm.70409","url":null,"abstract":"","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"27 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149230401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning Integrating Quantitative MRI and Clinical Features Predicts Loss of Ambulation in Duchenne Muscular Dystrophy 结合定量MRI和临床特征的机器学习预测杜氏肌营养不良患者的行动能力丧失
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-10-22 DOI: 10.1002/jcsm.70413
Chuan Liu,Yu Song,Jiayu Wan,Ting Xu,Xinyuan Zhang,Yiqiao Yan,Hang Fu,Xiaotang Cai,Yingkun Guo,Yun Wang,Huayan Xu
{"title":"Machine Learning Integrating Quantitative MRI and Clinical Features Predicts Loss of Ambulation in Duchenne Muscular Dystrophy","authors":"Chuan Liu,Yu Song,Jiayu Wan,Ting Xu,Xinyuan Zhang,Yiqiao Yan,Hang Fu,Xiaotang Cai,Yingkun Guo,Yun Wang,Huayan Xu","doi":"10.1002/jcsm.70413","DOIUrl":"https://doi.org/10.1002/jcsm.70413","url":null,"abstract":"","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"2 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149230395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underweight Versus Obesity and Gastrointestinal Cancer Mortality in Type 2 Diabetes: A Nationwide Cohort Study 体重不足与肥胖和2型糖尿病胃肠道癌症死亡率:一项全国性队列研究
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-10-21 DOI: 10.1002/jcsm.70408
Ji-Hong Park,Kyungdo Han,Hun Jee Choe,Se Eun Park,Won-Young Lee,Sun-Joon Moon,Eun-Jung Rhee
{"title":"Underweight Versus Obesity and Gastrointestinal Cancer Mortality in Type 2 Diabetes: A Nationwide Cohort Study","authors":"Ji-Hong Park,Kyungdo Han,Hun Jee Choe,Se Eun Park,Won-Young Lee,Sun-Joon Moon,Eun-Jung Rhee","doi":"10.1002/jcsm.70408","DOIUrl":"https://doi.org/10.1002/jcsm.70408","url":null,"abstract":"","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"25 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149230397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Denosumab Versus Zoledronic Acid for Muscle Strength and Physical Performance in Postmenopausal Osteoporosis: A 3-Year Prospective Study Denosumab与唑来膦酸对绝经后骨质疏松症患者肌肉力量和身体机能的影响:一项为期3年的前瞻性研究
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-10-21 DOI: 10.1002/jcsm.70406
Xiangwen Li,Zineng Yuan,Nina Ma,Bijuan Huang,Hongyue Tao,Shuang Chen
{"title":"Denosumab Versus Zoledronic Acid for Muscle Strength and Physical Performance in Postmenopausal Osteoporosis: A 3-Year Prospective Study","authors":"Xiangwen Li,Zineng Yuan,Nina Ma,Bijuan Huang,Hongyue Tao,Shuang Chen","doi":"10.1002/jcsm.70406","DOIUrl":"https://doi.org/10.1002/jcsm.70406","url":null,"abstract":"","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"33 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149230396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma Lipidome Is Dysregulated in Amyotrophic Lateral Sclerosis and Associated With Life-Course Adiposity Polygenic Risk 肌萎缩性侧索硬化症患者血浆脂质组失调并与生命过程中肥胖多基因风险相关
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-10-21 DOI: 10.1002/jcsm.70410
Linjing Zhang,Leyuan Zhang,Yongping Zheng,Zhenhuang Zhuang,Lu Tang,Wei Zheng,Kailin Xia,Shan Ye,Tielun Yin,Tao Huang,Dongsheng Fan
{"title":"Plasma Lipidome Is Dysregulated in Amyotrophic Lateral Sclerosis and Associated With Life-Course Adiposity Polygenic Risk","authors":"Linjing Zhang,Leyuan Zhang,Yongping Zheng,Zhenhuang Zhuang,Lu Tang,Wei Zheng,Kailin Xia,Shan Ye,Tielun Yin,Tao Huang,Dongsheng Fan","doi":"10.1002/jcsm.70410","DOIUrl":"https://doi.org/10.1002/jcsm.70410","url":null,"abstract":"","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"59 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149230399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated Single‐Myofibre Multi‐Omics Correlates Inflammatory State to Myosin Energetics in ICU‐Acquired Weakness 综合单-肌纤维多组学:ICU获得性虚弱患者炎症状态与肌球蛋白能量相关
IF 8.9 1区 医学
Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2026-10-19 DOI: 10.1002/jcsm.70407
Alexandra M. Winant, Roger Moreno‐Justicia, Lucia Paolini, Wout J. Claassen, Coen A. C. Ottenheijm, Atul S. Deshmukh, Stefano Cattaneo, Simone Piva, Nicola Latronico, Robert A. E. Seaborne, Julien Ochala
{"title":"Integrated Single‐Myofibre Multi‐Omics Correlates Inflammatory State to Myosin Energetics in ICU‐Acquired Weakness","authors":"Alexandra M. Winant, Roger Moreno‐Justicia, Lucia Paolini, Wout J. Claassen, Coen A. C. Ottenheijm, Atul S. Deshmukh, Stefano Cattaneo, Simone Piva, Nicola Latronico, Robert A. E. Seaborne, Julien Ochala","doi":"10.1002/jcsm.70407","DOIUrl":"https://doi.org/10.1002/jcsm.70407","url":null,"abstract":"Background Skeletal muscle atrophy is a pervasive complication of critical illness that worsens survival and recovery, yet remains poorly explained by current clinical or molecular markers. Methods To directly connect disease‐associated molecular states to the contractile machinery, this study combined sequential functional, transcriptomic and proteomic profiling of the same single human skeletal myofibres from critically ill patients in the intensive care unit with acquired weakness (ICU‐AW) and controls. This integrated approach provides a framework for validating molecular signals directly within the cellular and biomechanical context. Results Differential expression analyses between control and ICU‐AW myofibres show marked donor‐level heterogeneity, with no differentially expressed features (FDR &lt; 0.05). Ranked gene set enrichment analyses revealed distinct transcriptional and proteomic signatures between conditions, as well as a subtle yet conserved myofibre state enriched in ICU‐AW, characterised by inflammatory and chemotactic gene programmes, intracellular structural remodelling and bioenergetic adaptation. Nineteen features were significantly (FDR &lt; 0.05) altered at both RNA and protein levels from the same myofibre. Overall, these 19 overlapping features link an inflammatory transcriptional landscape to a proteomic shift toward mitochondrial and translational machinery, revealing a coordinated stress‐adaptation programme with selective post‐translational control in fibres from patients with ICU‐AW. Further integration with the functional dataset revealed fibres in this state displayed selectively disrupted myosin dynamics, evidenced by prolonged ATP turnover time of myosin heads in their super‐relaxed conformation, suggesting altered myosin energetics as a contributor to muscle dysfunction. Conclusions These findings define a discrete, disease‐associated myofibre state and validate a proof‐of‐concept integrative single‐fibre framework for connecting multi‐omic heterogeneity to molecular motor function in complex human disease. The identification of coordinated transcriptomic and proteomic programmes, validated through functional measurement, suggests that targeting this fibre state may offer new therapeutic opportunities in ICU‐acquired dysfunction and related muscle disorders.","PeriodicalId":186,"journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","volume":"48 1","pages":""},"PeriodicalIF":8.9,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149221331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书